Morel lavelle lesion

Reading File
Finding Sources
Searching PubMed

"Morel-Lavallee" lesion

Searching the Web

Morel-Lavallee lesion pathophysiology diagnosis management 2024

Reading File
Reading File
Reading File
Loading Image
Loading Image
Reading File
Loading Image
Finding Sources
Reading File
Reading File
I now have comprehensive information from multiple authoritative textbooks. Let me compile the full answer.

Morel-Lavallée Lesion

Definition and History

A Morel-Lavallée lesion (MLL) is a closed internal degloving injury first described by French surgeon Victor Auguste François Morel-Lavallée in 1863. It results from shearing forces that separate the skin and subcutaneous tissue from the underlying deep fascia, creating a potential space that fills with blood, lymph, necrotic fat, and debris.

Pathophysiology

Mechanism of Morel-Lavallée lesion - shearing of subcutaneous tissues from deep fascia
Figure: The shearing force displaces the mobile subcutaneous fat relative to the fixed deep fascia, tearing perforating arteries (red), veins (blue), and lymphatics (green), creating a haemolymphatic collection in the potential space between the superficial and deep fascial layers.
The injury occurs in regions where overlying skin is mobile and the underlying fascia is tough - classically the quadriceps fascia (superior to knee) and fascia lata (proximal lateral thigh). The shearing disrupts:
  • Lymphatic vessels
  • Locules of subdermal fat
  • Transaponeurotic capillaries
The resulting cavity fills with a mix of haemolymphatic fluid and necrotic fat. With time, a fibrous pseudocapsule may form. Importantly, up to 46% of "closed" lesions are culture-positive at initial debridement, making infection a major concern.
  • Campbell's Operative Orthopaedics 15th Ed 2026, Ch. 58
  • Bailey and Love's Short Practice of Surgery 28th Ed

Common Locations

  • Peritrochanteric / lateral hip and proximal thigh (most common)
  • Greater trochanter region
  • Buttock
  • Knee and distal thigh
  • Lumbar region
  • Less common: chest wall, breast, scalp
Approximately 8% of patients sustaining a blow to the greater trochanter have a clinically significant MLL.

Associated Injuries

MLL is frequently missed because it coexists with distracting bony injuries:
  • Pelvic fractures
  • Acetabular fractures
  • Proximal femur fractures
  • High-energy extremity trauma
It is especially common in obese individuals where the shear component of injury is amplified.

Clinical Presentation

Clinical appearance of large Morel-Lavallée lesion in thigh and buttock after pelvic fracture
Figure: A and B - Large Morel-Lavallée lesion in the thigh after pelvic fracture. Note the extensive ecchymosis and soft-tissue swelling.
Signs and symptoms:
  • Soft tissue swelling and ecchymosis over affected area
  • Fluctuance and compressibility of the swelling (fluid wave)
  • Hypermobility of overlying skin - a key diagnostic clue
  • Pain (may be disproportionately mild given lesion size)
  • Late presentations may include full-thickness skin necrosis

Imaging

MRI (modality of choice)

Signal characteristics evolve with lesion age:
PhaseT1T2
Acute (<1 week)HypointenseHyperintense
Subacute (1-6 weeks)Increasingly hyperintenseHyperintense
Chronic (>6 weeks)Heterogeneous (haemosiderin deposit)Heterogeneous
On MRI, the lesion appears as an elliptical/lobular mass in the deep subcutaneous fat, with:
  • Low-signal rim (chronic haemorrhage / fibrous capsule)
  • Heterogeneous internal contents (blood, fat, debris)
  • Possible rim enhancement
  • Fat-fluid levels

CT

  • Useful when MRI is unavailable; shows a hypodense fluid collection in subcutaneous tissue
  • The CT should be scrutinized in pelvic/acetabular fracture patients for any subcutaneous fluid collection

Ultrasound

  • Subcutaneous hypo-/anechoic collection
  • Point-of-care ultrasound (POCUS) is gaining traction for bedside diagnosis and drainage guidance
Grainger & Allison's Diagnostic Radiology; Pathologyoutlines.com

Differential Diagnosis

  • Post-operative seroma
  • Coagulopathy-related haematoma
  • Post-traumatic fat necrosis
  • Early myositis ossificans (with diffuse subcutaneous oedema)
  • Abscess

Why It Matters Clinically: Surgical Site Infection

The presence of an MLL overlying a planned operative approach significantly increases postoperative infection risk:
  • Infection rate reported as high as 12% with repeated debridement and secondary intention healing
  • Culture positivity in 46% of closed lesions at initial debridement
  • Lesions >50 mL are particularly high-risk (83% infection vs. 33% for <50 mL)
When planning acetabular/pelvic ORIF, the MLL should be treated before or at the time of fixation. Sometimes the anterior approach is chosen to avoid the affected lateral area.
  • Campbell's Operative Orthopaedics 15th Ed 2026, Ch. 60 (Acetabulum)

Management

There is no universally accepted treatment algorithm. Management is individualized based on lesion size, chronicity, location, and planned surgery.

Conservative / Non-operative

  • Compression bandaging: for small, acute lesions
  • Observation: associated with relatively low infection rates (~19%)
  • Best outcomes when managed acutely

Percutaneous Aspiration

  • Suitable for small, acute lesions
  • High recurrence rate
  • Higher infection rate (~56%) compared to observation or excision - thus often insufficient alone

Percutaneous Drainage (Tseng & Tornetta Technique)

Recommended within 3 days of injury for good results:
  1. 2-cm incision over the distal aspect of the lesion
  2. Second 2-cm incision at the superior/posterior extent
  3. Determine lesion extent with suction tip; add incisions as needed
  4. Send fluid for culture & sensitivity
  5. Drain haematoma with suction
  6. Debride loose fat with plastic brush
  7. Pulsed lavage until fluid is clear
  8. Place closed suction drain (to wall suction until output <30 mL/24h - may take ~8 days)
  9. Close incisions tightly
  10. IV cephalosporin (or culture-directed) for 24h post-drain removal

Open Surgical Debridement

  • Indicated for large lesions, chronic/infected lesions, or those overlying planned ORIF sites
  • Debride to a bleeding edge; do NOT use tourniquet (skin viability cannot be assessed)
  • Complications: massive wounds, risk of devascularizing overlying skin

Sclerotherapy

  • Doxycycline or talc injected into the cavity to obliterate the space
  • Used increasingly as a minimally invasive alternative
  • Useful for chronic or recurrent lesions

Key decision threshold (Rockwood & Green 2025):

Collections >50 mL are best treated surgically rather than with aspiration alone.
  • Campbell's Operative Orthopaedics 15th Ed 2026, Technique 58.1
  • Rockwood and Green's Fractures in Adults 10th Ed 2025, Table 16-13

Key Clinical Pearls

  • Frequently missed - always consider in pelvic/acetabular fracture patients, especially obese individuals
  • Hypermobility of skin or a palpable fluid wave should raise suspicion
  • Check CT for subcutaneous fluid in all high-energy pelvic trauma patients
  • Treat before ORIF or choose an approach that avoids the lesion
  • Percutaneous drainage with drain output <30 mL/day before ORIF is a validated strategy
  • Delayed or misdiagnosed lesions have higher infection and skin necrosis risk

Recent evidence (2025-2026): A 2026 systematic review (PMID 40905976) and a 2026 scoping review (PMID 41126680) confirm no consensus treatment algorithm exists; management remains individualized. These reviews echo that surgical treatment outperforms aspiration alone for larger lesions.
This is a shared conversation. Sign in to Orris to start your own chat.